A phase 2 study of GW572016 [lapatinib] for brain metastases in patients with HER2-positive breast cancer.
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2013
At a glance
- Drugs Lapatinib (Primary)
- Indications Advanced breast cancer; Brain metastases
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Sep 2005 New trial record.